These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30840447)

  • 41. Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
    Im W; Ban JJ; Chung JY; Lee ST; Chu K; Kim M
    Sci Rep; 2015 Nov; 5():16887. PubMed ID: 26586297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recently emerging signaling landscape of ataxia-telangiectasia mutated (ATM) kinase.
    Farooqi AA; Attar R; Arslan BA; Romero MA; ul Haq MF; Qadir MI
    Asian Pac J Cancer Prev; 2014; 15(16):6485-8. PubMed ID: 25169474
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.
    Chiang MC; Cheng YC; Nicol CJ; Lin KH; Yen CH; Chen SJ; Huang RN
    Exp Cell Res; 2015 Nov; 338(2):183-93. PubMed ID: 26362846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and toxicity of ATM inhibition in glioblastoma initiating cells-driven tumor models.
    Frosina G; Marubbi D; Marcello D; Vecchio D; Daga A
    Crit Rev Oncol Hematol; 2019 Jun; 138():214-222. PubMed ID: 31092378
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
    Fox JH; Barber DS; Singh B; Zucker B; Swindell MK; Norflus F; Buzescu R; Chopra R; Ferrante RJ; Kazantsev A; Hersch SM
    J Neurochem; 2004 Oct; 91(2):413-22. PubMed ID: 15447674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses.
    Overstreet JM; Samarakoon R; Cardona-Grau D; Goldschmeding R; Higgins PJ
    FASEB J; 2015 Apr; 29(4):1258-68. PubMed ID: 25480384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain.
    Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ
    Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.
    Martin B; Golden E; Carlson OD; Pistell P; Zhou J; Kim W; Frank BP; Thomas S; Chadwick WA; Greig NH; Bates GP; Sathasivam K; Bernier M; Maudsley S; Mattson MP; Egan JM
    Diabetes; 2009 Feb; 58(2):318-28. PubMed ID: 18984744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease.
    Klivenyi P; Ferrante RJ; Gardian G; Browne S; Chabrier PE; Beal MF
    J Neurochem; 2003 Jul; 86(1):267-72. PubMed ID: 12807446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis.
    Kurose A; Tanaka T; Huang X; Traganos F; Dai W; Darzynkiewicz Z
    Cytometry A; 2006 Apr; 69(4):212-21. PubMed ID: 16528719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in the response of MCF-7 cells to ionizing radiation after the combination of ATM and DNA-PK inhibition.
    Ćmielová J; Havelek R; Vávrová J; Řezáčová M
    Med Oncol; 2015 May; 32(5):138. PubMed ID: 25801233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N6-Furfuryladenine is protective in Huntington's disease models by signaling huntingtin phosphorylation.
    Bowie LE; Maiuri T; Alpaugh M; Gabriel M; Arbez N; Galleguillos D; Hung CLK; Patel S; Xia J; Hertz NT; Ross CA; Litchfield DW; Sipione S; Truant R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7081-E7090. PubMed ID: 29987005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
    Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
    Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
    Wang X; Sarkar A; Cicchetti F; Yu M; Zhu A; Jokivarsi K; Saint-Pierre M; Brownell AL
    J Neurol Sci; 2005 Apr; 231(1-2):57-66. PubMed ID: 15792822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics.
    Jin J; Gu H; Anders NM; Ren T; Jiang M; Tao M; Peng Q; Rudek MA; Duan W
    Neuromolecular Med; 2016 Dec; 18(4):581-592. PubMed ID: 27225841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.
    Iwahori S; Shirata N; Kawaguchi Y; Weller SK; Sato Y; Kudoh A; Nakayama S; Isomura H; Tsurumi T
    J Virol; 2007 Sep; 81(18):9653-64. PubMed ID: 17609267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase.
    Wang H; Guan J; Wang H; Perrault AR; Wang Y; Iliakis G
    Cancer Res; 2001 Dec; 61(23):8554-63. PubMed ID: 11731442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of Phosphodiesterases in Huntington's Disease.
    Fusco FR; Paldino E
    Adv Neurobiol; 2017; 17():285-304. PubMed ID: 28956337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies.
    Calabrese EJ; Bhatia TN; Calabrese V; Dhawan G; Giordano J; Hanekamp YN; Kapoor R; Kozumbo WJ; Leak RK
    Pharmacol Res; 2019 Dec; 150():104371. PubMed ID: 31415915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.